Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

NIBR-0213

Catalog No. T28169Cas No. 1233332-14-3
Alias NIBR 0213

NIBR-0213 is a potent and selective competitive S1P1 antagonist with activity against experimental autoimmune encephalomyelitis. In the GTPγ35S assay, it has IC50 values ​​of 2.0 nM and 2.3 nM for human and rat S1P1, respectively.

NIBR-0213

NIBR-0213

Purity: 98.87%
Catalog No. T28169Alias NIBR 0213Cas No. 1233332-14-3
NIBR-0213 is a potent and selective competitive S1P1 antagonist with activity against experimental autoimmune encephalomyelitis. In the GTPγ35S assay, it has IC50 values ​​of 2.0 nM and 2.3 nM for human and rat S1P1, respectively.
Pack SizePriceAvailabilityQuantity
1 mg$35In Stock
5 mg$77In Stock
10 mg$113In Stock
25 mg$229In Stock
1 mL x 10 mM (in DMSO)$108In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "NIBR-0213"

Select Batch
Purity:98.87%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
NIBR-0213 is a potent and selective competitive S1P1 antagonist with activity against experimental autoimmune encephalomyelitis. In the GTPγ35S assay, it has IC50 values ​​of 2.0 nM and 2.3 nM for human and rat S1P1, respectively.
Targets&IC50
S1P1:8.5 nM(GTPγ35S,mouse), S1P1:2.5 nM(Ca2+ mobilization), S1P1:2.3 nM(GTPγ35S,rat), S1P1:2.0 nM(GTPγ35S,human)
In vitro
In the Ca2+ assay, NIBR-0213 showed inhibitory activity against hS1P1 with an IC50 of 2.5 nM, but was inactive against S1P2, S1P3, and S1P4 (IC50 > 10 μM); in the GTPγ35S assay, NIBR-0213 showed potent and comparable potency against human and rat S1P1 (IC50 of 2.0 nM and 2.3 nM, respectively), while the IC50 for mouse S1P1 was slightly lower at 8.5 nM. [1]
In vivo
METHODS: NIBR-0213 (30, 100, 300 mg/kg, oral, once daily, for two weeks) was used to treat the rat adjuvant-induced arthritis (AiA) model to explore the functional/pathophysiological consequences of the disruption of S1P1-dependent vascular permeability homeostasis caused by its competitive antagonism.
RESULTS An effective oral dose of 30 mg/kg BID was tolerated without signs of dyspnea but induced dose-dependent acute vascular lung leak and pleural effusion, which completely resolved within 3-4 days; at a supramaximal oral dose of 300 mg/kg QD, NIBR-0213 impaired lung function (increased respiratory rate and decreased tidal volume) within the first 24 hours; NIBR-0213 at doses of 30, 100, and 300 mg/kg induced moderate lung changes after two weeks, characterized by alveolar wall thickening, macrophage accumulation, fibrosis, microhemorrhage, edema, and necrosis.[2]
AliasNIBR 0213
Chemical Properties
Molecular Weight464.98
FormulaC27H29ClN2O3
Cas No.1233332-14-3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/ml (118.28 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1506 mL10.7532 mL21.5063 mL107.5315 mL
5 mM0.4301 mL2.1506 mL4.3013 mL21.5063 mL
10 mM0.2151 mL1.0753 mL2.1506 mL10.7532 mL
20 mM0.1075 mL0.5377 mL1.0753 mL5.3766 mL
50 mM0.0430 mL0.2151 mL0.4301 mL2.1506 mL
100 mM0.0215 mL0.1075 mL0.2151 mL1.0753 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NIBR-0213 | purchase NIBR-0213 | NIBR-0213 cost | order NIBR-0213 | NIBR-0213 chemical structure | NIBR-0213 in vivo | NIBR-0213 in vitro | NIBR-0213 formula | NIBR-0213 molecular weight